Industry Events

The American Society of Breast Surgeons (ASBrS) is pleased to offer Industry Events to the breast surgery community. Webinars are educational programs sponsored and funded by an outside organization, independently organized, and offered, and have been made possible through marketing support and advertising fees. Content is updated as programming details are received. See below for Upcoming Events and on-demand events: 2021 & 2020.

Interested in Supporting an Activity or Webinar?

Please contact Marti Boyer at mboyer@breastsurgeons.org.


The following industry activities are supported by specific companies through marketing grants and advertising fees. They are not part of the official education program of the ASBrS, and most events are free to all members. By clicking the links posted below, please understand you may leave the ASBrS website and go to a website not operated by the Society.


Tuesday, December 14, 7:00 PM ET


Agendia

Genomic Profiling of Early Stage Breast Cancer: Expanding Applications to Improve Outcomes

Description:

This webinar will empower you with data demonstrating the utility of Agendia’s assays, MammaPrint® and BluePrint®, for patients with breast cancer. Review the latest data and learn about the real-world impact of MammaPrint and BluePrint. Please join us for an informative, interactive webinar.

Registration:


Note: This webinar is supported by Agendia through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.

October 13–15, 2022


Australasian International Breast Congress (AIBC)

Overview:

On October 13-15, 2022, the Australasian Society for Breast Disease (ASBD), World Congress on Controversies in Breast Cancer (CoBrCa) and Breast Surgeons of Australia and New Zealand (BreastSurgANZ), will hold an international congress focusing on controversial issues in breast diseases including presentations, debates and discussions. For more information, visit aib-congress.org.

Learn More:



Educational Grants & Marketing Support
Marketing support for the ASBrS 2021 Virtual Education Series is provided by Agendia, Ambry Genetics, Bayer, Cardinal Health, Genentech, Hologic, Mammotome, Medtronic, Merit Medical, Pacira BioSciences, Inc., Perimeter Medical Imaging AI, Inc., and Stryker.

3M+KCI

Agendia

Ambry Genetics

Bayer

Endomag

Exact Sciences

Hologic

Medtronic

Mammotome

Merit Medical

Pacira BioSciences, Inc.

Perimeter Medical Imaging AI, Inc.


3M+KCI

22nd Annual Meeting Symposium
Minimizing Post-operative Complications Following Major Breast Surgery


Description:

Please join us for a case-based discussion on innovative solutions that may minimize complications after challenging breast surgery cases. Contact Alexandra Castillo at acastillo8@mmm.com.


Note: Symposia at the Society's 22nd Annual Meeting were educational programs sponsored and funded by an outside organization, independently organized, and offered. This symposium was supported by 3M+KCI through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 4/30/2021

Agendia

22nd Annual Meeting Symposium
A Case-Based Discussion of Integrating MammaPrint and BluePrint into Treatment Planning for Patients with Early Stage Breast Cancer


Description:

This symposium will feature a case-based discussion of Mammaprint and Blueprint's clinical utility for patients with Early-Stage Breast Cancer. Pat Whitworth, MD, and William Audeh, MD, will discuss real world evidence and published clinical data in the context of patient care. Attendees will participate in an interactive Q&A at the end of the presentation.


Note: Symposia at the Society's 22nd Annual Meeting were educational programs sponsored and funded by an outside organization, independently organized, and offered. This symposium was supported by Agendia through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 4/30/2021

Agendia

A New Paradigm in Treatment Planning: Integrating Molecular Subtyping as Part of Comprehensive Genomic Profiling into Routine Clinical Care for Patients with Breast Cancer


Presenter:

  • William Audeh, MD
    Chief Medical Officer, Agendia

Discussant:

  • James Pellicane, MD
    Director of Breast Oncology, Bon Secours Cancer Institute

For More Information:

Contact Israel Madera at israel.madera@agendia.com.


Note: This webinar is supported by Agendia through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 2/16/2021

Ambry Genetics

Expanding Surgical Patient Reach: Earlier Detection through Integration of an End-to-End Solution


Description:

Join us as we discuss how to strengthen the patient and provider journey toward an individualized treatment plan. The CARE Program™ provides an end-to-end solution that can help identify high-risk patients earlier for potential proactive medical management and preventative procedures.

Brochure:

Access PDF

Speakers:

  • Anjali Date, MD
    Sheila R. Veloz Breast Center Lead Interpreting Physician
  • Mari Shay, BSN, RN
    Sheila R. Veloz Breast Center Manager, Women’s Imaging Services
  • Kory Jasperson, MS, CGC
    Director, Clinical Services, Ambry Genetics

Note: This webinar is supported by Ambry Genetics through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 3/16/2021

Bayer

Risk Stratified Breast Screening


Description:

Dr. Gillian Newstead (MD, FACR), Director of Global Breast Imaging at University of Chicago, will be talking about Risk Stratified Breast Screening and discussing the importance of breast density. She will share recommendations from the American College of Radiology and the American Society of Breast Surgeons and highlight the importance of supplemental Breast MRI screening for women with specific high risk factors, including women with dense breast tissue.

For More Information:

Contact Lainey Kasian at lainey.kasian@bayer.com.


Note: This webinar is supported by Bayer through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 8/24/2021

Endomag

22nd Annual Meeting Symposium
Tissue Localization – The Future is Paramagnetic


Description:

Presenting the latest data on seed localization, featuring results from iBRA-NET, the world’s largest multicenter seed localization study with over 1,000 patients and the latest findings for TAD with Magseed® from the University of Texas MD Anderson Cancer Center. This is followed by a roundtable Q&A and an exclusive sneak peek at the new Sentimag® Gen 3 platform. For more information, contact Mathew Stephens (mstephens@endomag.com) or Connor Jipps (cjipps@endomag.com).


Note: Symposia at the Society's 22nd Annual Meeting were educational programs sponsored and funded by an outside organization, independently organized, and offered. This symposium was supported by Endomag through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 5/1/2021

Exact Sciences

22nd Annual Meeting Symposium
De-escalating Breast Cancer Surgery with Neoadjuvant Endocrine Therapy


Description:

Dr. Christy Russell, Sr. Director of Global Medical Affairs at Exact Sciences, and Dr. Susan Boolbol, System Chief of the Breast Surgical Oncology and Breast Program at Nuvance Health, discuss the utility of neoadjuvant endocrine therapy to de-escalate breast and axillary surgery in HR-positive, HER2-negative breast cancer patients. The presentation will also review data pertaining to biomarkers used to make neoadjuvant treatment decisions, including the Oncotype DX Breast Recurrence Score® test. For more information, contact Thomas Mallick (tmallick@exactsciences.com).


Note: Symposia at the Society's 22nd Annual Meeting were educational programs sponsored and funded by an outside organization, independently organized, and offered. This symposium was supported by Exact Sciences through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 4/29/2021

Hologic

The Reconstructive Lumpectomy™: Beyond the Fundamentals–Techniques for the Breast Surgeon


Description:

A Live Hologic Virtual Course featuring Cadaveric Assessment and Surgical Skills Advancement. Each of the three recorded sessions include lecture and case examples presented by renowned faculty, cadaveric demonstration of skills, introduction to technology, interactive panel discussion, and the opportunity to ask questions of the panel.

Brochure:

Access PDF

Topics Include:

  • Applied Breast Anatomy
  • Aesthetic Scar Placement
  • Donut Mammoplasty and Modifications for all quadrants
  • Managing Complications in Oncoplastic Breast Surgery
  • Multi-Disciplinary Decision Making

Educational Objectives:

After completing this course, the surgeon will be able to:
  • Perform aesthetically state of the art surgeries with optimal outcomes
  • Understand how technology can reduce re-excisions, returns to OR, and deliver state of the art treatment in an ever-changing health care climate
  • Treat tumors in all quadrants without a plastic surgeon
  • Have a strong fundamental understanding of breast anatomy and aesthetics to proceed with other training in Level II procedures
  • Identify and spot red flags that would lead to poor outcomes

Criteria for Participation:

Practicing breast or general surgeons who perform breast cases, practicing radiologists and radiation oncologists also welcome. Hologic reserves the right to accept or decline any registration or request for attendance. Attendees are limited to those practicing surgery, radiology, or radiation oncology.


Note: This webinar is supported by Hologic through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 3/10/2021, 3/20/2021, 3/31/2021

Hologic

22nd Annual Meeting Symposium
Updates and Education on the Principles and Practice of BioZorb® 3D Marker Utilization


Description:

Join the conversation with breast surgeons and a radiation oncologist as they discuss the role of a BioZorb® marker in a Reconstructive Lumpectomy™ surgery as well as the recent publication of the BioZorb® registry in the Annals of Surgical Oncology. Topics include communication with patients and practicing a multidisciplinary approach to patient care.

Faculty:

  • Dr. Cary Kaufman
  • Dr. Kiran Devisetty
  • Dr. Ashley Richardson
  • Dr. Lorraine Tafra

Note: Symposia at the Society's 22nd Annual Meeting were educational programs sponsored and funded by an outside organization, independently organized, and offered. This symposium was supported by Hologic through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 5/1/2021

Mammotome

22nd Annual Meeting Symposium
Modernizing Axillary Management: Delayed SLNB for DCIS Patients


Description:

How can you spare up to 78% of high-risk DCIS patients axillary surgery? Join a panel of surgical experts as they discuss how they’re taking patient care to the next level with tailored axillary management procedures and sparing some patients SLNB.

  • Roundtable Discussion
  • Procedure Videos
  • Downloadable Resources

Note: Symposia at the Society's 22nd Annual Meeting were educational programs sponsored and funded by an outside organization, independently organized, and offered. This symposium was supported by Mammotome through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 4/30/2021

Medtronic

Insights from the Nipple Sparing Mastectomy Registry & Related Trending Topics


Description:

Join our Faculty for a one-hour webinar as they take a closer look at the ASBrS Nipple Sparing Registry data. Jay Harness, MD will moderate a panel discussion with Shawna Willey, MD, Beth DuPree, MD and William Scarlett, DO as they review how data insights can drive improvement of care and reduce complications in Nipple Sparing Mastectomies. We encourage audience participation, discussion and questions at the end. Please join us for an informative, interactive webinar.

Brochure:

Access PDF

Objectives:

  • Evaluate the Nipple Sparing Mastectomy Registry Data and discuss how the results can be used to influence patient outcomes.
  • Review the science behind technologies that can help drive more efficient and effective care.
  • Discuss breast reconstruction options, including the considerations for patient selection.
  • Understand how to reduce complications using impact of technique, proper incision placements and tumescence in surgery.

Target Audience:

  • Breast Surgeons
  • General Surgeons
  • Plastic Surgeons
  • Healthcare Providers

Faculty:

  • Dr. Jay Harness
  • Dr. Shawna Willey
  • Dr. Beth DuPree
  • Dr. William Scarlett

Questions:

Contact Kirsten Gonya at kirsten.m.gonya@medtronic.com.


Note: This webinar is supported by Medtronic through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 3/2/2021

Medtronic

22nd Annual Meeting Symposium
Mitigating Risks & Complications in Nipple Sparing Mastectomies


Description:

Join our Faculty, Shawna Willey, MD, William Scarlett, DO, and Jay Harness, MD, for a one-hour virtual event as they take a closer look at Nipple Sparing Mastectomy risks & complications. They will discuss the importance of patient selection, the complication rates associated with various measurements, surgical approaches, and the benefits of the tools and technologies used in NSM. We encourage audience participation, discussion and questions at the end. For more information, contact Kirsten Gonya (kirsten.m.gonya@medtronic.com).


Note: Symposia at the Society's 22nd Annual Meeting were educational programs sponsored and funded by an outside organization, independently organized, and offered. This symposium was supported by Medtronic through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 4/30/2021

Merit Medical

Think Wire-Free w/ Dr. Madrigrano and Dr. Murphy. Advanced Utilization of SCOUT® Radar Localization for Breast Cancer Surgery


Presentation Highlights:

  • Utility for Oncoplastic Approaches
  • Targeted Axillary Dissection
  • Utility of Access Guide for Small Incisions
  • Case Reviews

Note: This webinar is supported by Merit Medical through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 6/16/2021

Merit Medical

Think Wire-Free w/ Dr. Barry Rosen and Dr. Mary Hayes. Post-COVID Strategies to Optimize Breast Cancer Care: A Patient-Centered Model


Description:

Join Advocate Health’s Barry Rosen, MD, and Memorial Healthcare’s Mary Hayes, MD, to learn how they uniquely employed SCOUT Radar Localization throughout the patient care continuum and throughout their systems to achieve streamlined, patient-centered care.

Brochure:

Access PDF

Presentation Highlights:

  • Cost and clinical advantages derived from going Wire-Free
  • Reducing patient facility visits through localizing with SCOUT at biopsy & data review
  • Clinical utility of SCOUT for Mastectomy and Oncoplastic approaches

Speakers:

  • Barry Rosen, MD, FACS
    Breast Team Leader, Advocate Healthcare, Chicago, IL
    Managing Partner, Targeted Medical Education (TME)
    Assistant Professor of Surgery Univeristy of Illinois College of Medicine
  • Mary K. Hayes, MD
    Former Medical Director and Chief of Women’s Imaging at Memorial Healthcare System and Envision

Note: This webinar is supported by Merit Medical through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 1/26/2021

Merit Medical

22nd Annual Meeting Symposium
The Preferred Localization Solution to Treat More Patients: SCOUT


Description:

SCOUT Radar localization exclusively spans the care continuum from time of biopsy placement to Targeted Axillary Dissection to excellent surgical outcomes. Discover the state-of-the art localization techniques practiced by key opinion leaders from the Cleveland Clinic, Columbia University, University of Colorado, Intermountain Healthcare and the Advocate System.


Note: Symposia at the Society's 22nd Annual Meeting were educational programs sponsored and funded by an outside organization, independently organized, and offered. This symposium was supported by Merit Medical through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 4/30/2021

Pacira BioSciences, Inc.

Optimizing Outpatient Breast Surgery: A Multidisciplinary Panel Discussion


Description:

The panel will evaluate critical factors in optimizing surgical results and recovery across in- and outpatient settings, including:

  • Patient selection and engagement
  • Communication, multimodal and culture change
  • Integrating experience and techniques from plastic surgery

Moderated by:

  • Shawna Willey, MD
    Peterson Chair of Breast Cancer Research
    Inova Schar Cancer Institute
    Inova Fairfax Hospital

Panelists:

  • Mark Brzezienski, MD
    University of Tennessee Health Science Center
    Professor of Plastic and Orthopedic Surgery
    Chairman and Program Director Department of Plastic Surgery
  • Jeff Gonzales, MD
    Staff Anesthesiologist
    Parker Adventist Hospital
  • Stephanie Valente, DO
    Breast Surgeon
    Cleveland Clinic

Questions:

For questions, please contact Erin.Fitzpatrick@pacira.com.


Note: This webinar is supported by Pacira BioSciences, Inc., through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 2/3/2021

Perimeter Medical Imaging AI, Inc.

Is OCT the Next Game Changer in Margin Visualization?


Description:

Join us as we present multiple patient cases using a new FDA-cleared intraoperative specimen imaging technology for real-time margin visualization of excised tissue and shaved margins with surgeons from three prestigious institutions involved in Perimeter’s clinical trials. This webinar provides a deeper dive on Optical Coherence Tomography (OCT) – an established, ultra high-resolution technology used in cardiology, dermatology and ophthalmology – and correlates OCT images to histopathology.

Brochure:

Access PDF

Speakers:

  • Nina Tamirisa, MD
    Assistant Professor, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
  • Maryam Elmi, MD
    Assistant Professor, Division of Surgical Oncology & Endocrine Surgery, University of Texas Health Science Center, San Antonio, TX
  • Stacey Carter, MD, FACS
    Assistant Professor of Surgery, Division of Surgical Oncology, Breast Surgery Section, Baylor College of Medicine, Houston, TX

Contact Information:

For more information, contact Andrew Berkeley at aberkeley@perimetermed.com or sales@perimetermed.com or call 214‑845‑5154.


Note: This webinar is supported by Perimeter Medical Imaging AI through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 10/5/2021

Perimeter Medical Imaging AI, Inc.

Next Generation in Surgical Specimen Imaging with Future AI Enhancements


Description:

Learn more about advancements in intraoperative specimen imaging. Optical Coherence Tomography (OCT), a high-resolution imaging modality commonly used in ophthalmology and cardiology, is ideally suited to visualizing margins during a surgical procedure. This webinar also includes insights into how Artificial Intelligence is moving towards the OR and Specimen Imaging.

Brochure:

Access PDF

Presentation Highlights

  • Intraoperative Specimen Imaging and the Role of OCT
  • OCT in the Operating Room and Case Reviews
  • Applying to AI to OCT Specimen Imaging

Speakers:

  • Hank Schmidt, MD, PhD
    Associate Professor of Surgery, Mount Sinai School of Medicine, Dubin Breast Center, Tisch Cancer Institute, New York, NY
  • Beth DuPree, MD, FACS, ABOIM
    Medical Director Oncology Service Line Centers of Northern Arizona at Northern Arizona Healthcare, AZ
  • Alastair Thompson, BSc (Hons), MBChB, MD, FRCS (Ed)
    Professor and Chief, Section of Breast Surgery, Division of Surgical Oncology, Bayor College of Medicine

Contact Information:

For more information, contact Andrew Berkeley at aberkeley@perimetermed.com.


Note: This webinar is planned and executed by Perimeter Medical Imaging AI, Inc. and promoted/shared by ASBrS through a paid marketing campaign. It is not part of the official education program of the ASBrS and will not meet any of the training criteria requirements of the ASBrS Oncoplastic Surgery Certification.
Originally Aired: 3/23/2021

Educational Grants & Marketing Support

Marketing support for the ASBrS 2021 Virtual Education Series is provided by Agendia, Ambry Genetics, Cardinal Health, Genentech, Hologic, Mammotome, Medtronic, Merit Medical, Pacira BioSciences, Inc., Perimeter Medical Imaging AI, Inc., and Stryker.

Marketing support for the ASBrS 2021 Annual Meeting is provided by 3M+KCI, Agendia, Endomag, Exact Sciences, Hologic, Mammotome, Medtronic, and Merit Medical.

The following events previously aired in 2021. On-demand recordings are currently unavailable.

Monday, November 8, 7:00–8:00 PM ET


PeerView Institute for Medical Education

Raising the Bar in HR+/HER2- Early Breast Cancer: Multidisciplinary Strategies for Integrating the CDK4 and 6 Inhibitors

Description:

Orally bioavailable CDK4 and 6 inhibitors have become established standard-of-care options in HR+/HER2- metastatic breast cancer, and these agents are now expected to have a major impact in early breast cancer (EBC). CDK4 and 6 inhibition has recently shown significant benefit as adjuvant therapy in patients at high risk of early recurrence, but other studies in the adjuvant and neoadjuvant settings are under way as well. How should these advances be transitioned to the clinic based on the accumulating supportive evidence? How can surgeons and oncologists work together to ensure proper risk assessment and treatment planning to improve outcomes in patients with HR+/HER2- EBC? This PeerView Live Virtual Workshop will provide pertinent updates on the most recent research and available evidence on CDK4 and 6 inhibition in HR+/HER2- EBC, as well as practical, case-based guidance on the application of these agents using individualized treatment plans and effective multidisciplinary collaboration.

CME Provider:

MLI, Medical Learning Institute, Inc.


Note: This webinar is supported by PVI, PeerView Institute for Medical Education, through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.

Tuesday, October 19, 7:30–8:30 PM ET


Cardinal Health

How to Navigate the Impact of COVID-19 on Your Breast Cancer Practice

Description:

In honor of Breast Cancer Awareness Month, we invite you to join a complimentary webinar led by Linda Han, MD, FACS, PPG, Director of Breast Oncology at the Parkview Cancer Institute, where she will discuss the impact of COVID-19 on breast cancer care. During this hour-long webinar we’ll walk through:

  • How to screen safely
  • Best practices for following guidelines
  • The impact on cancer-related mortality
  • And provide a forum for Dr. Han to answer your questions

About the Speaker:

Linda Han, MD, FACS, PPG
Director of Breast Oncology
Parkview Cancer Institute

Dr. Han currently serves as the Director of Breast Oncology at Parkview Cancer Institute and Chief Surgery Quality and Optimization Officer for Parkview Health in Fort Wayne, Indiana. She continues to remain active in surgical education as an adjunct professor of clinical surgery and has received numerous teaching awards for excellence in resident and medical student education.


Note: This webinar is supported by Cardinal Health through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.

Thursday, October 14, 7:00–8:00 PM ET


Stryker

Ask the Expert: Advancements in Breast Cancer Surgery

Description:

Join us during Breast Cancer Awareness Month for a discussion on advances in oncoplastic breast cancer surgery including technologies, techniques, trends and addressing disparities in care. Live Q&A to follow.

Faculty

Allison DiPasquale, MD
Methodist Medical Center
Dallas, TX

Anne Peled, MD
Sutter Health California Pacific Medical Center
San Francisco, CA


Note: This webinar is supported by Stryker through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.

Tuesday, September 28, 7:00 PM ET


Hologic

Enhancement of Cavity Delineation
Using Modern Radiation Techniques in Breast Cancer

Description:

Join the conversation with 3 radiation oncologists as we discuss the Surgery / Radiation Oncology partnership. Discuss the important role of Hologic’s BioZorb® 3D Bioabsorbable Marker as a communication device. Learn steps and processes to move to shorter courses of therapy and improve clinical efficiency. Hear about prone accelerated Partial Breast Irradiation after breast-conserving surgery.

Brochure: Access PDF

Panelists:

Kiran Devisetty, MD
Memorial Health University Medical Center
Savannah, GA

John Ng, MD
Weill Cornell Medical College/New York Presbyterian Hospital
New York, NY

Asal Rahimi, MD
UT Southwestern Medical Center
Dallas, TX


Note: This webinar is supported by Hologic through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.

Tuesday, July 27, 7:00 PM ET


Hologic

Implementing LOCalizer® Wire-free Surgical Guidance System in Clinical Practice

What makes the LOCalizer System’s RFID technology so useful in the OR?

Dr. Michele Blackwood, Chief of Breast Services at RWJ Barnabas Health, New Jersey, will:

  • Share her experience with the LOCalizer System
  • Offer procedural tips on reducing the learning curve when implementing the technology in your OR
  • Discuss the design and functionality of the LOCalizer system, including explaining the multi-directionality of the probe

Dr. Blackwood will also address questions from participants.

Brochure: Access PDF

Speaker:

Michele Blackwood, MD, FACS, is Chief, Section Breast Surgery at Rutgers Cancer Institute of New Jersey, and Professor of Surgery at Rutgers Robert Wood Johnson Medical School. In addition, she serves as Medical Director at The Center for Breast Health and Disease Management at the Barnabas Health Ambulatory Care Center. As Northern Regional Director for RWJBH, Dr. Blackwood oversees breast cancer surgical and clinical services, programs and initiatives at Saint Barnabas Medical Center (SBMC), Clara Maass Medical Center (CMMC), Jersey City Medical Center (JCMC) and Newark Beth Israel (NBI).

Contact:

The administrator for this event is Ronda Hannon who can be reached at 203‑263‑0006 x107


Note: This webinar is supported by Hologic through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.

Monday, July 19, 7:30 PM ET


Hologic

Intraoperative Margin Evaluation of Breast Specimens: A multi-disciplinary approach and the role of specimen imaging

A multidiscplinary panel will discuss:

  • The importance of intraoperative specimen and margin assessments
  • The impact of maintaining control over specimen orientation, and specimen imaging workflow for a surgical excision

This includes case studies and perspectives from a pathologist, a pathologist assistant and a surgeon as they discuss the technology, how it works and the impact of specimen radiography on efficiency, grossing and other related topics. Our panelists will address your questions live.

Brochure: Access PDF

Panelists

Anthony Lucci, MD, FACS Moderator
Breast Surgeon; Professor, Dept. of Breast Surgical Oncology,
The University of Texas MD Anderson Cancer Center

Aysegul Sahin, MD
Pathologist; Professor, Dept. of Pathology,
Division of Pathology/Lab Medicine,
The University of Texas MD Anderson Cancer Center

Hollis Notgrass, MS, PA(ASCP)
Lead Pathologists Assistant,
UT Southwestern Medical Center


Note: This webinar is supported by Hologic through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.

Wednesday, May 12, 7:00 PM ET


Mammotome

New Axillary Staging Procedure: Delayed SLNB with Radiation-Free Mapping
Should All DCIS Patients Receive a SLNB?

Description:

Only a small proportion of DCIS patients are upgraded to IBC, sparing approximately 78% of DCIS patients from SLNB surgery. A panel of surgical experts discuss their experience leveraging a magnetic liquid tracer to tailor treatment for DCIS patients.

  • Round Table Discussion
  • Live surgical video of procedure
  • Live Q&A

Note: This webinar is supported by Mammotome through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.

Saturday, May 8, 12:00–4:15 PM ET


Stryker

Intermediate Oncoplastic Techniques Teleconference (Level 2)

Description:

Led by distinguished faculty, this intermediate course is intended for breast and plastic surgeons who are already proficient in basic oncoplastic techniques and want to advance their oncoplastic skills. Through live lectures, group discussions and surgical videos, attendees will be exposed to level 2/intermediate oncoplastic techniques including marking, technique selection, oncoplastic mastopexy/reduction, nipple-sparing mastectomy, and optimizing outcomes through a team approach.

Brochure: Access PDF

Course Director:

Anne Peled, MD
Dual-trained breast and plastic surgeon
Co-Director, Sutter California Pacific Medical Center Breast Center of Excellence
Clinical Faculty, University of California, San Francisco
San Francisco, CA

Faculty:

Nicholas Clavin, MD
Plastic surgeon
Assistant Professor, Atrium Health, Charlotte, NC

Allison DiPasquale, MD
Breast surgeon
Director of Oncology, Methodist Hospital
Professor of General Surgery Resident Program
Board of Directors, Susan G Komen, Dallas
Dallas, TX

Tripp Holton, MD
Plastic surgeon
Chief and Medical Director, Anne Arundel Medical Center
Annapolis, MA

For More Information:

Contact Kimmy Sullivan at kimmy.sullivan@stryker.com


Note: This webinar is planned and executed by Stryker and promoted/shared by ASBrS through a paid marketing campaign. It is not part of the official education program of the ASBrS and will not meet any of the training criteria requirements of the ASBrS Oncoplastic Surgery Certification.

Tuesday, Apr 20, 7:00–8:00 PM ET


Cardinal Health

Delivering Efficiency in Sentinel Lymph Node Biopsy

Description:

Join Dr. Vincent Reid for a free CE webinar to learn how Mercy Medical Center observed short procedure times and low pain scores, while adding new surgical cases in a 30-day trial. Following the presentation will be a live Q&A with Dr. Reid.

Speaker:

  • Vincent Reid, MD
    • Chairman, Department of Surgery, Mercy Medical Center
    • Associate Professor of Surgery, Division of Surgical Oncology and Endocrine Surgery, The University of Iowa Hospitals and Clinics

For more information, Contact Us.


Note: This webinar is supported by Cardinal Health through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.

Thursday, Mar 18, 3:00–4:00 PM ET


Cardinal Health

Advances in Lymphatic Mapping and Sentinel Lymph Node Biopsy in Breast Cancer Care

Description:

Join Dr. Linda Han and Dr. Vincent Reid for a webinar about advances in lymphatic mapping and sentinel lymph node biopsy in breast cancer care. You will hear the latest advances in lymphatic mapping and sentinel lymph node biopsy, results of a patient case study, and have the opportunity to ask our presenters questions about their own clinical experience.

Speakers:

  • Linda Han, MD
    • Director of Breast Oncology, Parkview Cancer Institute
    • Adjunct Clinical Professor of Surgery, Indiana University School of Medicine
  • Vincent Reid, MD
    • Chairman, Department of Surgery, Mercy Medical Center
    • Associate Professor of Surgery, Division of Surgical Oncology and Endocrine Surgery, The University of Iowa Hospitals and Clinics

For more information, Contact Us.


Note: This webinar is supported by Cardinal Health through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.

Saturday, Mar 6, 12:00–4:15 PM ET


Stryker

Introductory Oncoplastic Techniques Teleconference (Level 1)

Description:

Led by distinguished faculty, this introductory course is intended for general and breast surgeons who want to become proficient in oncoplastic techniques and incorporate them into their practice. Through live lectures, group discussions and surgical videos, attendees will be exposed to level 1/beginner oncoplastic techniques including patient evaluation, marking, de-epithelization, oncoplastic lumpectomy and cavity closure, crescent mastopexy, and technique selection.

Brochure: Access PDF

Course Director:

Anne Peled, MD
Dual-trained breast and plastic surgeon
Co-Director, Sutter California Pacific Medical Center Breast Center of Excellence
Clinical Faculty, University of California, San Francisco
San Francisco, CA

Faculty:

Allison DiPasquale, MD
Breast surgeon
Director of Oncology, Methodist Hospital
Professor of General Surgery Resident Program
Board of Directors, Susan G Komen, Dallas
Dallas, TX

Robert Gabordi, MD
Breast surgeon
Medical Director Breast Oncology, St. Joseph's Hospitals
Tampa, FL

Monique Gary, DO, FACS
Breast surgeon
Medical Director, Grand View Health/Penn Medicine Network
Director, NAPBC Accredited Breast Program
Director, Cancer Genetic Risk and Prevention Program
Sellersville, PA

Bridget O'Brien, DO, FACS
Breast surgeon
Medical Director, St David's Breast Care Center
Austin, TX

For More Information:

Contact Kimmy Sullivan at kimmy.sullivan@stryker.com


Note: This webinar is planned and executed by Stryker and promoted/shared by ASBrS through a paid marketing campaign. It is not part of the official education program of the ASBrS and will not meet any of the training criteria requirements of the ASBrS Oncoplastic Surgery Certification.

Tuesday, Feb 23, 7:00 PM ET


Genentech

Updates on HER2+ Breast Cancer Therapies—Learn about a subcutaneous option for patients with HER2+ breast cancer that can be given in minutes

Faculty:

Dr. Eleftherios Mamounas MD, MPH, FACS
Professor Of Surgery- Northeast Ohio Medical University
Professor Of Surgery- University Of Central Florida, College of Medicine
Clinical Professor of Clinical Sciences- Florida State University, College of Medicine

Invitation: Access PDF

Join us to hear Dr. Eleftherios Mamounas discuss a HER2+ Breast Cancer therapy, which can be administered to patients subcutaneously and given over a few minutes. During the 30 minute webinar, Dr. Mamounas will provide a product overview including indications, important safety information, dosing, and administration details. In addition, he will review clinical trial results including patient preference data.


Note: This webinar is supported by Genentech through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.

Wednesday, Feb 10, 7:00–8:30 PM ET


Stryker

Taking Nipple-Sparing Mastectomy to the Next Level

Description:

Join a panel of experts to discuss advances in technique, innovative technologies and challenging cases.

Brochure: Access PDF

Faculty:

Anne Peled, MD
Dual-trained breast and plastic surgeon
Co-Director, Sutter California Pacific Medical Center Breast Center of Excellence
Clinical Faculty, University of California, San Francisco
San Francisco, CA

Tripp Holton, MD
Plastic surgeon
Chief and Medical Director, Anne Arundel Medical Center
Annapolis, MA

Robert Gabordi, MD
Breast surgeon
Medical Director Breast Oncology, St. Joseph's Hospitals
Tampa, FL

Sunny Mitchell, MD
Breast surgeon
Director of Breast Surgery, Medical Director, The Breast Center at Montefiore Nyack Hospital
Nyack, NY

For More Information:

Contact Kimmy Sullivan at kimmy.sullivan@stryker.com


Note: This webinar is planned and executed by Stryker and promoted/shared by ASBrS through a paid marketing campaign. It is not part of the official education program of the ASBrS and will not meet any of the training criteria requirements of the ASBrS Oncoplastic Surgery Certification.

Agendia

Exact Sciences Corporation

Hologic

Mammotome

Medtronic

Myriad Genetics, Inc.

PeerView Institute


Agendia

From NBRST to MINDACT: The Clinical Utility of BluePrint and MammaPrint in the Pre- and Post-Operative Treatment Settings


Presenter:

  • Alberto Montero, MD; Director Breast Cancer Program, UH Seidman Cancer Center; Associate Professor, CWRU School of Medicine

Discussant:

  • James Pellicane, MD; Director of Breast Oncology, Bon Secours Cancer Institute

Description:

Please join our webinar for an interactive discussion of comprehensive genomic profiling and how it can facilitate patient-centered care. Dr. Montero will provide updates on the NBRST and MINDACT clinical trials and discuss the utility of MammaPrint and BluePrint in the pre- and post-operative treatment settings with Dr. Pellicane. We look forward to an impactful webinar and welcome audience participation during the Q&A session.

For More Information:

Contact Israel Madera, israel.madera@agendia.com.


Note: This webinar is supported by Agendia through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 10/19/2020

Exact Sciences (formerly Genomic Health, Inc.)

Less is More: De-escalation of Local and Systemic Therapy with the Breast Recurrence Score® Test


Presenters:

  • Julia White, MD, Ohio State University Comprehensive Cancer Center
  • Anthony Lucci, MD, University of Texas, MD Anderson Cancer Center
  • Moderated by Christy Russell, MD, Exact Sciences

Note: This satellite symposium is supported by Exact Sciences Corporation (formerly Genomic Health, Inc.) through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 5/28/2020

Hologic

Panel Discussion: Optimal Surgical Treatment of Breast Reconstruction & Localization with Cases


Description:

An interactive panel discussion designed to highlight optimal breast reconstruction, localization techniques, and radiation planning along with specimen radiography through examination of actual cases and outcomes. Participants will have an opportunity to ask questions, share perspectives and hear about the latest breast reconstruction methods from a multi-disciplinary team including surgery, radiology, and radiation oncology practicing in both academic and community-based centers.

Speakers:

  • Karen Barbosa, DO, FACOS
    Breast Surgeon
    University of Maryland Shore Regional Health, Clark Comprehensive Breast Center

  • Anthony Lucci, MD, FACS
    Department of Breast Surgical Oncology, Division of Surgery
    MD Anderson Cancer Center

  • Joshua Mondschein, MD, MSCI, DABR
    Radiation Oncologist
    Tennessee Oncology / Provisions Proton Therapy

For More Information:

Please contact MedEd-BSH@hologic.com.


Note: This symposium is supported by Hologic, Inc. through a marketing grant. It is not part of the official education program of the ASBrS.
Originally Aired: 6/22/2020

Mammotome

Changing the Standard of Care for Breast Surgery: Implementing Wire-Free Localization & Radiation-Free SLNB


Description:

Learn how Dr. McGuire is implementing wire-free localization and radiation-free SLNB technology that is changing her patient flow and improving outcomes. Advanced techniques such as delayed SLNB are now options for her patients.

1 Category A CEU, ASRT Approved

Presenter:

  • Kandace McGuire, MD, Virginia Commonwealth University

Note: This webinar is supported by Mammotome through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 5/13/2020

Mammotome

Leveraging Your Biopsy Markers (Part One): From Placement to Surgery


Description:

  • Review how the latest trends in NACT and Endocrine Therapy are changing patient flow
  • Learn how a marker can optimize patient care
  • Review case studies
  • Live Q&A

Note: This webinar is supported by Mammotome through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 11/4/2020

Mammotome

Leveraging Your Biopsy Markers (Part Two): Localization and Beyond


Description:

  • Advanced techniques of localizing with ultrasound
  • Review how the latest trends in NACT and Endocrine Therapy are changing patient flow
  • Review case studies
  • Live Q&A

Note: This webinar is supported by Mammotome through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 11/10/2020

Mammotome

Radiation-Free Targeted Axillary Dissection


Description:

Join Dr. Michael Alvarado as he discusses how to reduce your false negative rates with radiation-free targeted axillary dissection. Watch video demonstrations of Dr. Alvarado performing TAD and hear how using innovative localizing technology is improving outcomes for his patients.

Presenter:

  • Michael Alvarado, MD, University of San Francisco

Note: This webinar is supported by Mammotome through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 7/29/2020

Medtronic

Let’s Talk About: The Pandemic’s Impact on Breast Surgery IV


Description:

Join our faculty for a one-hour webinar as they discuss the pandemic’s impact on breast surgery. Jay Harness, MD will moderate a panel discussion with Shawna Willey, MD, Beth DuPree, MD, and William Scarlett, DO, as they exchange ideas and reflect on experiences around COVID-19 and the future of breast surgery. We encourage audience participation, discussion, and questions at the end. Please join us for an informative, interactive webinar.

Moderator:

  • Jay Harness, MD

Speakers:

  • Beth DuPree, MD
  • William Scarlett, DO
  • Shawna Willey, MD

For More Information:

Learn about PLASMABLADE™, Precise Soft Tissue Dissection Devices, or call 1‑866‑777‑9400.


Note: This webinar is supported by Medtronic through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 7/13/2020

Myriad Genetics, Inc.

Personalizing Breast Cancer Risks Beyond BRCA. riskScore®: Using the Next Generation of Risk Models for a More Precise and Personalized Cancer Risk


Description:

We will discuss how riskScore® is a precision medicine tool clinically validated to predict a woman’s risk of developing breast cancer. We will illustrate how it analyzes family history, personal clinical risk factors, and over 80 well-studied genetic markers to predict the risk of developing breast cancer over the next 5 years and remaining lifetime. In addition, we will cover possible advances such as expanding its availability to all ancestries and leveraging it to refine the risk for mutation carriers.

Brochure:

Access PDF

Program Objectives:

  1. Describe how riskScore® analyzes over 80 well-studied genetic markers and combined with the Tyrer-Cuzick model estimates a woman’s risk for developing breast cancer
  2. Learn how the model was validated and can be utilized in clinic today
  3. Summarize how the utilization of polygenic risk scores significantly modifies the risk of patients who carry a mutation

Speaker:

  • Thomas Slavin, MD, FACMG, DABCC
    SVP, Medical Affairs - Oncology | Myriad Genetics, Inc.

Note: This webinar is supported by Myriad Oncology through a marketing grant. It is not part of the official education program of the ASBrS. This activity is free to all members.
Originally Aired: 7/20/2020

PeerView Institute

The Era of Immuno-Oncology in TNBC: Navigating Evidence in Early-Stage & Advanced Disease, Practicalities of Integration, and Implications for Breast Surgeons


Description:

Immunotherapy has become a new pillar in the treatment arsenal for advanced triple-negative breast cancer (TNBC), and accumulating evidence is supporting its expansion into earlier disease stages as well. To make the most of this therapeutic approach as a component of multimodal management of patients, especially in curative intent settings, it is increasingly more important for breast surgeons, medical oncologists, radiation oncologists, pathologists, and other healthcare professionals to collaborate and coordinate the care of patients with TNBC.

This PeerView Live webcast provides up-to-date information and multidisciplinary perspectives on the current and emerging roles of immune checkpoint inhibitors and combinations throughout the disease continuum of TNBC, as well as practical guidance for optimal integration of these therapies into clinical practice, focusing on the most important implications for breast surgeons.

For More Information:

Contact PeerView at 1‑877‑833‑6141 or live@PeerView.com.


Note: This webinar is supported by Merck & Co., Inc., through an independent educational grant provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. CME credits for this program will be provided by Medical Learning Institute, Inc. It is not part of the official program of the ASBrS. This activity is free to all members.
Originally Aired: 8/13/2020

Educational Grants & Marketing Support
The ASBrS 2020 Virtual Education Series is supported through educational grants provided by 3M + KCI, Ambry Genetics, BD/Bard, Exact Sciences Corporation (formerly Genomic Health, Inc.), Genentech, Hologic, Inc., Invitae, John Wayne Cancer Foundation, Merck & Co., Inc., and TME and marketing support provided by Agendia, Ambry Genetics, Cardinal Health, Endomag, Exact Sciences Corporation (formerly Genomic Health, Inc.), Genentech, Hologic, Inc., Kubtec Medical Imaging, Mammotome, Medtronic, Myriad Genetics, Inc., PeerView Institute, and Stryker.